These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30484734)

  • 1. Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors.
    Constantine GD; Kessler G; Graham S; Goldstein SR
    J Womens Health (Larchmt); 2019 Feb; 28(2):237-243. PubMed ID: 30484734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
    Prentice RL; Manson JE; Langer RD; Anderson GL; Pettinger M; Jackson RD; Johnson KC; Kuller LH; Lane DS; Wactawski-Wende J; Brzyski R; Allison M; Ockene J; Sarto G; Rossouw JE
    Am J Epidemiol; 2009 Jul; 170(1):12-23. PubMed ID: 19468079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
    Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
    J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use.
    L'Hermite M
    Climacteric; 2017 Jun; 20(3):205-211. PubMed ID: 28509626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping menopausal hormone therapy: if breast cancer really decreased, why did colorectal cancer not increase?
    Nahum GG; Stanislaw H; Simon JA
    Maturitas; 2012 Apr; 71(4):354-9. PubMed ID: 22300685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
    Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
    [No Abstract]   [Full Text] [Related]  

  • 8. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review.
    Files J; Kling JM
    Expert Opin Drug Deliv; 2020 Apr; 17(4):543-549. PubMed ID: 31795776
    [No Abstract]   [Full Text] [Related]  

  • 10. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
    Chlebowski RT; Aragaki AK
    Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women.
    Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K
    Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal estrogens and progestogens and the incidence of gynecologic cancer.
    Weiss NS; Hill DA
    Maturitas; 1996 Mar; 23(2):235-9. PubMed ID: 8735361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.